Assessment of Effectiveness of Belatacept Patient Alert Card in Patients Following Renal Transplantation in a Sample of EU Countries
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure
- Status
- COMPLETED
- Phase
- PHASE4
An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis
- Status
- TERMINATED
- Phase
- PHASE1
Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Compare the Pharmacokinetics of Belatacept Using Active Pharmaceutical Ingredient Manufactured by Process E Relative to Process C
- Status
- COMPLETED
- Phase
- PHASE1
Apixaban in Atrial Fibrillation Registry
- Status
- COMPLETED
- Phase
- N/A
Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)
- Status
- WITHDRAWN
- Phase
- PHASE2
Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized, Open-Label Study of Daclatasvir and Sofosbuvir With or Without Ribavirin for 8 Weeks in Treatment-Naïve, Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 3
- Status
- WITHDRAWN
- Phase
- PHASE2
Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients
- Status
- COMPLETED
- Phase
- NA
Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS
- Status
- COMPLETED
- Phase
- N/A
Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study
- Status
- COMPLETED
- Phase
- N/A
A Comparative Study in Chinese Subjects With Chemotherapy Naïve Stage IV Melanoma Receiving Ipilimumab (3 mg/kg) vs. Dacarbazine
- Status
- COMPLETED
- Phase
- PHASE3
A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable Viremia
- Status
- COMPLETED
- Phase
- PHASE2